Wearable CGM bionsensor dev BioLinq raises $10m

Biosensor developer Biolinq said today it closed a $10 million Series A financing round to support its wirelessly-enabled biosensor patch designed for continuous monitoring of biomarkers, with an initial focus on monitoring glucose in diabetes patients.

The round was led by M Ventures in collaboration with Hikma Ventures and joined by Grey Sky Venture Partners, Three Leaf Ventures, LifeSci Venture Partners and individual donators, the San Diego, Calif.-based company said.

Read the whole story on our sister site, Drug Delivery Business

The post Wearable CGM bionsensor dev BioLinq raises $10m appeared first on MassDevice.

from MassDevice http://ift.tt/2hT7mVw